about
ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferationPERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.Cyclin D1, cancer progression, and opportunities in cancer treatment.Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry.Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma.Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma.Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cellsTargeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinomaRole and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors[HBx protein and its down-streaming molecules in hepatocellular carcinomas][Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors]SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitorsOverview of Glutamine Dependency and Metabolic Rescue ProtocolsStructural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cellsGlutamine addiction: an Achilles heel in esophageal cancers with dysregulation of CDK4/6Effect of early enteral nutrition on laparoscopic common bile duct exploration with enhanced recovery after surgery protocols
P50
Q35899955-51E0B615-C283-491A-ACCE-0A5A2B591100Q36224716-4740D350-C366-4344-BF31-252716A3ECB0Q38970431-C58BB076-4AA4-40AC-8A04-80AD327C0BD7Q39997019-2ECFB133-28F0-425C-8428-976AF55248FAQ46089793-6B41F066-837C-4B46-93DF-937280C414A2Q55497559-4CFEDC1D-CC3B-4DE5-90CC-5A32509A86ACQ57050042-7991AE21-13BD-4900-AB84-270D6F484F8CQ64066924-151E8BB3-CAAE-4338-9A54-09A81AA48FEDQ80664973-568A4747-34ED-4EC3-ACF3-4BE63FBFFA33Q81355859-85D87273-2A28-4CCA-97E8-F292F855F191Q84212983-978A50CC-2844-48C6-A9B4-93A25C1A0671Q90294248-FFA3D825-6873-4BBC-B226-3A126EFD1BEBQ91375316-F7B4F06C-8E4E-44CF-8CBC-0DD33832279AQ92153523-EE454238-A3C3-46C0-99E4-1027ECA5F443Q92354837-8E9FE30F-CF5B-4B61-BB26-69EF5F411B1FQ92842548-9CA1228A-F2C4-4E9B-A705-EB1DFED74FE8Q92987439-E401FD52-9107-4374-8715-17432AFC4B5F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Shuo Qie
@en
Shuo Qie
@nl
type
label
Shuo Qie
@en
Shuo Qie
@nl
prefLabel
Shuo Qie
@en
Shuo Qie
@nl
P31
P496
0000-0002-3481-3582